Bewersdorf JP, Derkach A, Gowda L, Menghrajani K, et al. Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant. Leuk Lymphoma 2021;62:3394-3401.
PMID: 34477024